Is Divis Labs (DIVISLAB) Halal?

NSE Healthcare India $1.6T
✓ HALAL
Confidence: 95/100
Divis Labs (DIVISLAB) is Halal under all 5 major Shariah screening standards. With a debt ratio of just 0.0% against the AAOIFI threshold of 30%, Divis Labs comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from March 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 0.0%
/ 30%
2.1%
/ 30%
1.6%
/ 30%
3.16%
/ 5%
✓ HALAL
DJIM 0.0%
/ 33%
2.1%
/ 33%
1.6%
/ 33%
3.16%
/ 5%
✓ HALAL
MSCI 0.0%
/ 33%
20.9%
/ 33%
16.1%
/ 33%
3.16%
/ 5%
✓ HALAL
S&P 0.0%
/ 33%
2.1%
/ 33%
1.6%
/ 33%
3.16%
/ 5%
✓ HALAL
FTSE 0.0%
/ 33%
20.9%
/ 33%
16.1%
/ 50%
3.16%
/ 5%
✓ HALAL

Financial Highlights

P/E Ratio
64.1
Forward: 51.3
EPS
$93.56
Dividend Yield
50.0%
Payout: 32.1%
P/B Ratio
10.3
EV/EBITDA
46.4
EV: $1.6T
Revenue
$93.2B
Growth: 12.3%
Beta
0.1
Low volatility

Profitability

Gross Margin 61.7%
Operating Margin 29.6%
Net Margin 24.0%

Cash Flow & Balance Sheet

Operating Cash Flow$16.5B
Free Cash Flow$2.1B
Total Debt$40M
Debt-to-Equity0.6
Total Assets$169.3B

Price & Trading

Last CloseINR 6,014.50
50-Day MAINR 6,174.83
200-Day MAINR 6,341.88
Avg Volume362K
Beta0.1
52-Week Range
INR 4,955.00
INR 7,071.50

About Divis Labs (DIVISLAB)

CEO
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Employees
10,542
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
India
Exchange
NSE
Market Cap
$1.6T
Currency
INR

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Purification Calculator

As a halal stock with 3.16% impermissible income, you need to purify your dividends.

Enter your dividends to calculate purification amount

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Divis Labs (DIVISLAB) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Divis Labs is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Divis Labs's debt ratio?

Divis Labs's debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.0%.

Does Divis Labs require dividend purification?

Yes, Divis Labs has an impermissible income ratio of 3.16%, which means 3.16% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.

What are Divis Labs's key financial metrics?

Divis Labs has a market capitalization of $1.6T, trailing P/E ratio of 64.1, and revenue of $93.2B. The company maintains a gross margin of 61.7% and a net margin of 24.0%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.